Siga Technologies (SIGA) Operating Income (QoQ) (2010 - 2025)
Analysis
Siga Technologies (SIGA) Operating Income (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -122.38% |
| Jun 30, 2025 | 2,125.36% |
| Mar 31, 2025 | -103.95% |
| Dec 31, 2024 | 10,430.77% |
| Sep 30, 2024 | -49.80% |
| Jun 30, 2024 | -90.42% |
| Mar 31, 2024 | -87.70% |
| Dec 31, 2023 | 7,102.29% |
| Sep 30, 2023 | 71.77% |
| Jun 30, 2023 | -120.00% |
| Mar 31, 2023 | -16.82% |
| Dec 31, 2022 | -104.21% |
| Sep 30, 2022 | 1,296.19% |
| Jun 30, 2022 | 313.41% |
| Mar 31, 2022 | -101.53% |
| Dec 31, 2021 | 3,293.90% |
| Sep 30, 2021 | -267,240.56% |
| Jun 30, 2021 | 100.06% |
| Mar 31, 2021 | -107.42% |
| Dec 31, 2020 | -18.53% |